Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NeurogesX Inc (OTC Pink - No Information:NGSX)

0.004
Delayed Data
As of Feb 04
 0.00 / 0.00%
Today’s Change
0.00
Today|||52-Week Range
0.02
+14.29%
Year-to-Date
No recent news for NeurogesX Inc.

Today’s Trading

Previous close0.00
Today’s openn.a.
Day’s range-- - --
Volume0
Average volume (3 months)43,873
Market cap$133.3K
Dividend yield--
Data as of 02/04/2016

Growth & Valuation

Earnings growth (last year)+14.34%
Earnings growth (this year)+65.58%
Earnings growth (next 5 years)--
Revenue growth (last year)+39.16%
P/E ratioNM
Price/Sales1.64
Price/Book--

Competitors

No competitors data available.

Financials

Last reporting dateMarch 7, 2013
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$11.5M
Annual profit (last year)-$49.5M
Net profit margin-430.71%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Operating Officer, CFO, Secretary &
EVP
Stephen F. Ghiglieri
Chief Medical Officer &
Executive Vice President
Stephen J. Peroutka
Corporate headquarters
San Mateo, California

Forecasts

Partner Offers